Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Kenney

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Human & Experimental Toxicology|November 1, 1995
Pharmacokinetic, pharmacodynamic, and pharmacotoxic profiles of recombinant-methionyl human interleukin-2[alanine-125] (r-metHuIL-2[ala-125]) following intravenous and subcutaneous administration in ratsC P LeBel, L Langlois, D P Bell, et al.
The Journal of Clinical Investigation|September 1, 1995
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing woundsG F Pierce, J E Tarpley, J Tseng, et al.
Biochemical and Biophysical Research Communications|October 31, 1988
Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coliL B Tsai, H S Lu, W C Kenney, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Human & Experimental Toxicology|November 1, 1995
Pharmacokinetic, pharmacodynamic, and pharmacotoxic profiles of recombinant-methionyl human interleukin-2[alanine-125] (r-metHuIL-2[ala-125]) following intravenous and subcutaneous administration in ratsC P LeBel, L Langlois, D P Bell, et al.
The Journal of Clinical Investigation|September 1, 1995
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing woundsG F Pierce, J E Tarpley, J Tseng, et al.
Biochemical and Biophysical Research Communications|October 31, 1988
Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coliL B Tsai, H S Lu, W C Kenney, et al.
Pageof 8